These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 7517174

  • 21. Mitochondrial targeting of JNK/SAPK in the phorbol ester response of myeloid leukemia cells.
    Ito Y, Mishra NC, Yoshida K, Kharbanda S, Saxena S, Kufe D.
    Cell Death Differ; 2001 Aug; 8(8):794-800. PubMed ID: 11526432
    [Abstract] [Full Text] [Related]

  • 22. Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas.
    Brown DM, Phipps RP.
    J Immunol; 1996 Aug 15; 157(4):1359-70. PubMed ID: 8759715
    [Abstract] [Full Text] [Related]

  • 23. Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents.
    Kobayashi T, Ruan S, Clodi K, Kliche KO, Shiku H, Andreeff M, Zhang W.
    Oncogene; 1998 Mar 26; 16(12):1587-91. PubMed ID: 9569026
    [Abstract] [Full Text] [Related]

  • 24. Induction of apoptosis in prostatic tumor cell line DU145 by staurosporine, a potent inhibitor of protein kinases.
    Zhang H, Hoang T, Saeed B, Ng SC.
    Prostate; 1996 Aug 26; 29(2):69-76. PubMed ID: 8700802
    [Abstract] [Full Text] [Related]

  • 25. Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53.
    Vrana JA, Decker RH, Johnson CR, Wang Z, Jarvis WD, Richon VM, Ehinger M, Fisher PB, Grant S.
    Oncogene; 1999 Nov 25; 18(50):7016-25. PubMed ID: 10597302
    [Abstract] [Full Text] [Related]

  • 26. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity.
    Vanhaesebroeck B, Reed JC, De Valck D, Grooten J, Miyashita T, Tanaka S, Beyaert R, Van Roy F, Fiers W.
    Oncogene; 1993 Apr 25; 8(4):1075-81. PubMed ID: 8455935
    [Abstract] [Full Text] [Related]

  • 27. Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members.
    Laane E, Panaretakis T, Pokrovskaja K, Buentke E, Corcoran M, Söderhäll S, Heyman M, Mazur J, Zhivotovsky B, Porwit A, Grandér D.
    Haematologica; 2007 Nov 25; 92(11):1460-9. PubMed ID: 18024393
    [Abstract] [Full Text] [Related]

  • 28. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S, Bullock G, Nuñez G, Tang C, Ibrado AM, Huang Y, Bhalla K.
    Cell Growth Differ; 1996 Dec 25; 7(12):1617-23. PubMed ID: 8959329
    [Abstract] [Full Text] [Related]

  • 29. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.
    Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC.
    Oncogene; 1994 Jun 25; 9(6):1799-805. PubMed ID: 8183579
    [Abstract] [Full Text] [Related]

  • 30. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes.
    Lotem J, Sachs L.
    Leukemia; 1996 Jun 25; 10(6):925-31. PubMed ID: 8667646
    [Abstract] [Full Text] [Related]

  • 31. Production of differentiation-inhibiting factor in cultured mouse myeloid leukemia cells treated with retinoic acid.
    Takenaga K, Honma Y, Okabe-Kado J, Hozumi M.
    Cancer Res; 1981 May 25; 41(5):1948-53. PubMed ID: 6938304
    [Abstract] [Full Text] [Related]

  • 32. The Bax alpha:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia.
    Salomons GS, Brady HJ, Verwijs-Janssen M, Van Den Berg JD, Hart AA, Van Den Berg H, Behrendt H, Hählen K, Smets LA.
    Int J Cancer; 1997 Jun 11; 71(6):959-65. PubMed ID: 9185697
    [Abstract] [Full Text] [Related]

  • 33. Bcl-2 inhibits glucocorticoid-induced apoptosis but only partially blocks calcium ionophore or cycloheximide-regulated apoptosis in S49 cells.
    Caron-Leslie LA, Evans RB, Cidlowski JA.
    FASEB J; 1994 Jun 11; 8(9):639-45. PubMed ID: 8005391
    [Abstract] [Full Text] [Related]

  • 34. Bcl-2 expression and glucocorticoid-induced apoptosis of leukemic and lymphoma cells.
    Smets LA, van den Berg JD.
    Leuk Lymphoma; 1996 Jan 11; 20(3-4):199-205. PubMed ID: 8624457
    [Abstract] [Full Text] [Related]

  • 35. Modulation of cell competence for induction of differentiation in myeloid leukemic cells.
    Symonds G, Sachs L.
    J Cell Physiol; 1982 Apr 11; 111(1):9-14. PubMed ID: 7045142
    [No Abstract] [Full Text] [Related]

  • 36. Control of programmed cell death in normal and leukemic cells: new implications for therapy.
    Sachs L, Lotem J.
    Blood; 1993 Jul 01; 82(1):15-21. PubMed ID: 8324219
    [Abstract] [Full Text] [Related]

  • 37. Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells.
    Trepel JB, Colamonici OR, Kelly K, Schwab G, Watt RA, Sausville EA, Jaffe ES, Neckers LM.
    Mol Cell Biol; 1987 Jul 01; 7(7):2644-8. PubMed ID: 3039354
    [Abstract] [Full Text] [Related]

  • 38. Expression of differentiation-related phenotypes and apoptosis are independently regulated during myeloid cell differentiation.
    Terui Y, Furukawa Y, Sakoe K, Ohta M, Saito M.
    J Biochem; 1995 Jan 01; 117(1):77-84. PubMed ID: 7775402
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Regulation of apoptosis in S49 cells.
    Hughes FM, Cidlowski JA.
    J Steroid Biochem Mol Biol; 1994 Jun 01; 49(4-6):303-10. PubMed ID: 8043493
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.